Press release – price-sensitive
21/03/2023
16/02/2023
18/01/2023
17/11/2022
28/10/2022
28/09/2022
15/09/2022
07/07/2022
27/06/2022
20/05/2022
18/05/2022
13/05/2022
29/04/2022
28/04/2022
21/04/2022
06/04/2022
06/04/2022
05/04/2022
04/04/2022
30/03/2022
21/12/2021
23/11/2021
05/11/2021
NOTICE OF CHANGE IN SHARE CAPITAL PURSUANT TO THE "DISCIPLINE ON TRANSPARENCY"
29/10/2021
01/10/2021
28/09/2021
27/09/2021
25/06/2021
ARTERRA BIOSCIENCE S.P.A. SUBSCRIBES SHARE OF THE CAPITAL INCREASE OF ADL FARMACEUTICI S.R.L. AND A NEW RESEARCH AND DEVELOPMENT CONTRACT
SIGNING OF A COLLABORATION AGREEMENT WITH MONTECARLOFRUIT
07/05/2021
29/04/2021
07/04/2021
06/04/2021
PUBLICATION OF THE CALL FOR THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING
29/03/2021
THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2020
15/02/2021
PROFESSOR VINCENZO FOGLIANO JOINS ARTERRA BIOSCIENCE AS CHIEF SCIENTIFIC OFFICER
28/12/2020
FINANCIAL CALENDAR FOR THE YEAR 2021
03/11/2020
EXERCISE OF 26,313 WARRANTS DURING THE FIRST YEAR PERIOD - ADJUSTMENT TO THE PRESS RELEASE OF OCTOBER 29, 2020
29/10/2020
ARTERRA COMMUNICATES THE CLOSURE OF THE FIRST EXERCISE PERIOD OF THE ARTERRA WARRANTS 2019-2022
01/10/2020
ARTERRA COMMUNICATES THE OPENING OF THE FIRST EXERCISE PERIOD OF THE ARTERRA WARRANTS 2019-2022
30/09/2020
THE BOARD OF DIRECTORS APPROVED THE HALF-YEAR REPORT AS OF JUNE 30, 2020
04/08/2020
A PATENT RELATING TO THE IDENTIFICATION OF A NATURAL COMPOUND CAPABLE OF INTERFERING WITH COVID-19 INFECTION WITH POSSIBLE APPLICATIONS IN DIFFERENT INDUSTRIAL SECTORS HAS BEEN FILED
03/07/2020
ARTERRA COMMUNICATES THE SUBSCRIPTION OF THE ADDENDUM TO VITALAB’S SHAREHOLDER AGREEMENT WITH THE INTERCOS GROUP
30/06/2020
ARTERRA COMMUNICATES THE EXTENSION OF THE DEADLINE FOR THE APPOINTMENT OF THE CFO TO JUNE 30, 2021
29/06/2020
ARTERRA COMMUNICATES THE FREE ALLOCATION OF SHARES IN FAVOR OF ITS EMPLOYEES
19/06/2020
ARTERRA COMMUNICATES THE FREE ALLOCATION OF SHARES IN FAVOR OF ITS EMPLOYEES
29/05/2020
TAX CREDIT RECOGNIZED FOR COSTS RELATED TO THE IPO
15/05/2020
WEEKLY INFORMATION REGARDING THE PURCHASE OF TREASURY SHARES
08/05/2020
WEEKLY INFORMATION REGARDING THE PURCHASE OF TREASURY SHARES
30/04/2020
WEEKLY INFORMATION REGARDING THE PURCHASE OF TREASURY SHARES
29/04/2020
ORDINARY SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.
24/04/2020
WEEKLY INFORMATION REGARDING THE PURCHASE OF TREASURY SHARES
17/04/2020
WEEKLY INFORMATION REGARDING THE PURCHASE OF TREASURY SHARES
10/04/2020
WEEKLY INFORMATION REGARDING THE PURCHASE OF TREASURY SHARES
02/04/2020
ARTERRA LAUNCHES THE REPURCHASE PROGRAM OF ORDINARY TREASURY SHARES
31/03/2020
THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2019
17/02/2020
VALUE OF THE PRODUCTION 2019 - TAX CREDIT - NEW RESOURCES
27/11/2019
EXERCISE OF THE GREENSHOE OPTION
14/11/2019
THE BOARD OF DIRECTORS OF ARTERRA BIOSCIENCE S.P.A. APPROVES THE QUARTERLY FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2019
28/10/2019
FIRST TRADING DAY OF ARTERRA'S ORDINARY SHARES AND WARRANTS ON THE AIM ITALIA MARKET
28/10/2019
FINANCIAL CALENDAR FOR THE YEAR 2020
24/10/2019
10/10/2019
ARTERRA BIOSCIENCE S.P.A. BOOKBUILDING LAUNCHED PRE-ADMISSION APPLICATION SUBMITTED.